Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
News Analysis
Nature Reviews Drug Discovery 7, 971–972 (1 December 2008) | doi:10.1038/nrd2662
Targeting apoptosis: selected anticancer strategies
Abstract
Selective modulation of the apoptotic machinery has been the goal of oncology developers for more than two decades. The field continues to face special challenges.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
